extract the authors and their orgnizations :3-Heterocyclyl quinolone inhibitors of the HCV NS5B polymerase NAME_1, Roopa NAME_2,⇑, NAME_3, NAME_4, NAME_5, NAME_6, NAME_7, NAME_8, NAME_9, NAME_10, NAME_11, NAME_12, NAME_13, NAME_14, NAME_15 aMyrexis Inc., 305 Chipeta Way, Salt Lake City, UT 84108, USA bAlios BioPharma, 260 E. Grand Ave., South San Francisco, CA 94080, USA cPrincipia Biopharma, 400 E. Jamie Ct., South San Francisco, CA 94080, USA dCelgene Corp., 4550 Towne Centre Ct., San Diego, CA 92121, USA eGilead Sciences Inc., 333 Lakeside Drive, Foster City, CA 94404, USA fInterMune Inc., 3280 Bayshore Blvd., NAME_16, CA 94005, USA gTheravance, Inc., South San Francisco, CA 94080, USA hCrown Bioscience, No.6 Beijing West Road, Taicang City, Jiangsu Province 215400, PR China iGenentech Inc., 1 DNA Way, South San Francisco, CA 94080, USA jAllosteros Therapeutics, 1230 Bordeaux Drive, Sunnyvale, CA 94089, USA kEli Lilly and Company, 10300 Campus Point Drive, Suite 200, San Diego, CA 9212, USA lInnovation Pathways, 20 Palo Alto Ave., Palo Alto, CA 94031, USA mVirobay, Inc., 1490 O’Brien Drive, Menlo Park, CA 94025, USA article info Article history: Received 13 September 2011 Revised 2 November 2011 Accepted 3 November 2011Available online 9 November 2011 Keywords: HCVNS5B polymerase inhibitors3-Heterocyclyl quinolone analogsNNI-2 bindersabstract T Write your response with at least 150 words.
user